Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Bristol Myers Squibb CO Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 3,200,215 shares of BMY stock, worth $186 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,200,215
Previous 2,901,220
10.31%
Holding current value
$186 Million
Previous $120 Million
37.45%
% of portfolio
0.18%
Previous 0.15%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,532Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.24 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.41 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.54 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.55 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $124B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...